Work

First-biopsy diagnostic rate in sinonasal malignant lymphoma: a single-center retrospective study of 24 cases

Year: 2026
Type: article
Study design: Observational Study
Abstract: Sinonasal malignant lymphoma accounts for approximately 1% of head and neck malignancies, and necrosis often precludes diagnosis on a single biopsy. To determine the first-biopsy diagnostic rate by site of origin, histologic subtype, and biopsy method, and to describe the modifications made at repeat biopsy in non-diagnostic cases. We retrospectively reviewed 24 patients with sinonasal malignant lymphoma at a single university hospital (2014–2024; median age 68.5 years; 15 men, 9 women). Subtypes were diffuse large B-cell lymphoma (DLBCL; 12), extranodal NK/T-cell lymphoma (ENKL; 8), MALT lymphoma (2), and others (2); sites were the nasal cavity (12) and maxillary (6), ethmoid (5), and sphenoid (1) sinuses. The overall first-biopsy diagnostic rate was 70.8% (17/24): 75.0% for DLBCL (9/12) and ENKL (6/8), 83.3% (10/12) for the nasal cavity, and 58.3% (7/12) for the paranasal sinuses (p = 0.371). Five of seven non-diagnostic cases involved the paranasal sinuses, with only non-specific inflammation and necrosis. Approximately 30% of cases were not diagnosed at the first biopsy, mostly paranasal sinus lesions. Although site differences were not significant, clinicians should anticipate repeat biopsy for paranasal sinus lesions; general anesthesia may be considered when adequate sampling is difficult under local anesthesia.
Source: Figshare
Language: English
Field: Medicine
Open Access status: green
OpenAlex ID: W7235013517
FWCI:
Cites:
Cited by:
Related to: 10